
Sign up to save your podcasts
Or


Chairman & CEO Sean McCarthy walks us through the science and describes what CytomX has learned about it over many years of working on masking. He discusses the recent EpCAM data, and highlights IFN-α2b and partnered programs.
By BiotechTV5
44 ratings
Chairman & CEO Sean McCarthy walks us through the science and describes what CytomX has learned about it over many years of working on masking. He discusses the recent EpCAM data, and highlights IFN-α2b and partnered programs.

30,636 Listeners

1,872 Listeners

1,086 Listeners

325 Listeners

6,086 Listeners

60 Listeners

9,852 Listeners

86 Listeners

34 Listeners

19 Listeners

260 Listeners

500 Listeners

0 Listeners

4 Listeners

2 Listeners

6 Listeners